Oncological Sciences News
Mar 6, 2019 10:00 AM
Welcome new Assistant Professor Dr. Xiaoyang Zhang!
Dr. Zhang uses state-of-the art genomics approaches to understand how germline and somatic genomic alterations reshape the landscape of regulatory enhancer elements, cause epigenetic and transcriptional dysregulation, and promote cancer development. His particular focus in on squamous cell carcinomas (primarily of the lung) with a long-term goal of discovering novel therapeutic vulnerabilities for cancer treatment.